RJA
BSX icon

Raymond James & Associates’s Boston Scientific BSX Stock Holding History

Raymond James & Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,000
Closed -$31.4K – 3895
2022
Q4 		$31.4K Buy
+26,000
New +$1.13M ﹤0.01% 3754
2022
Q3 		– Sell
-15,000
Closed -$2K – 3964
2022
Q2 		$2K Sell
15,000
-31,000
-67% -$1.26M ﹤0.01% 3999
2022
Q1 		$8K Buy
+46,000
New +$1.99M ﹤0.01% 4070
2018
Q2 		– Sell
-17,100
Closed -$162K – 3599
2018
Q1 		$162K Sell
17,100
-2,800
-14% -$76.1K ﹤0.01% 3194
2017
Q4 		$99K Buy
19,900
+400
+2% +$11K ﹤0.01% 3209
2017
Q3 		$182K Sell
19,500
-500
-3% -$13.8K ﹤0.01% 3078
2017
Q2 		$157K Hold
20,000
– – ﹤0.01% 3046
2017
Q1 		$105K Hold
20,000
– – ﹤0.01% 3066
2016
Q4 		$41K Hold
20,000
– – ﹤0.01% 3102
2016
Q3 		$80K Buy
20,000
+700
+4% +$16.7K ﹤0.01% 3032
2016
Q2 		$69K Sell
19,300
-300
-2% -$6.49K ﹤0.01% 2854
2016
Q1 		$4K Buy
+19,600
New +$344K ﹤0.01% 2908

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Raymond James & Associates's BSX Position: Q3 2024 in Review

Raymond James & Associates increased its Boston Scientific (BSX) stake by 15% in Q3 2024, buying an estimated $13.8M and bringing the position to 1,327,349 shares worth $111M. The position accounts for 0.07% of the portfolio, ranked #246.

Raymond James & Associates first reported a position in BSX in Q2 2013 and has held it in 46 quarters since. 1,396 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Raymond James & Associates held 1,327,349 shares of Boston Scientific worth $111M as of Q3 2024.
  • Raymond James & Associates bought 175,294 Boston Scientific shares in Q3 2024, an estimated $13.8M.
  • Boston Scientific made up 0.07% of Raymond James & Associates's portfolio in Q3 2024, its #246 holding.
  • Raymond James & Associates first reported a position in Boston Scientific in Q2 2013 and has held it in 46 quarters since.
  • 1,396 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.